Pharmacogenomics Study of CPT-11 as the First-lineChemotherapy for SCLC.
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Irinotecan (Primary) ; Antineoplastics; Cisplatin
- Indications Small cell lung cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 24 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register record.
- 23 Jan 2013 Planned end date changed from 1 Aug 2013 to 31 Aug 2013 as reported by Chinese Clinical Trial Register record.
- 05 Sep 2011 New trial record